My CML Journey
Living With Chronic Myeloid Leukemia
A personal record of treatment, blood results, diet, and the everyday experience of living with CML.
This is a personal experience, not medical advice. My prescribed treatment remains essential, and I do not interpret changes in my results as caused by juicing or plant-based eating.
My Story
Over five years ago, I was diagnosed with Chronic Myeloid Leukemia (CML).
My diagnosis completely changed how I viewed my health and the food I ate. I started learning more about nutrition, juicing, and plant-based eating.
Today, I continue taking dasatinib every day and monitoring my BCR-ABL levels through regular blood tests.
My results have improved over the years, although there have been fluctuations along the way. Accepting that I may need lifelong treatment hasn’t always been easy.
Chillgreen is where I share my experience, recipes, progress, and what I’ve learned about living with CML.
My plant-based lifestyle is something I value, but my medication remains essential to managing my leukemia.
My Diagnosis & Early Treatment
Diagnosis
I was given medication to lower my white blood cell count and was admitted to the hospital for about 2 weeks.



After Discharge


At first, I was told to take 100 mg dasatinib. It went well, and my BCR-ABL went down significantly, reaching around 0.1%.
But after 1–2 years, it more or less stopped going down and stayed around that level.
My doctor then suggested changing my medication to nilotinib. I had side effects from that medication, and my blood results were not very good. It affected my red blood cells, so I switched back to dasatinib, but at a higher dose of 140 mg.
That went more smoothly in terms of side effects, but my results still felt stuck. Around that time, I decided to start juicing about 1 kg of carrots a day. After a few weeks, I went back for my follow-up visit and my blood results came back normal, while my BCR-ABL dropped significantly to around 0.08%.
For me, I strongly felt the carrots helped, although I know that is my personal belief and not something scientifically proven.
After that, I continued juicing and gradually added more vegetables such as celery and beetroot. Over time, I kept seeing further improvement in my BCR-ABL results.
I also realized that variety mattered, not just quantity. Now I usually make two juices — a red juice and a green juice — and also smoothies, mainly using berries.
I intentionally try to consume a variety of colors, especially purple, green, and red, because different colors contain different antioxidants.
Later on, I also reduced my dasatinib to 70 mg, and my results still became even better.
At the moment, I’m continuing to explore how to include even more plant foods in my routine, such as papaya leaf juice and different teas.
Personal note: This is my personal experience and interpretation. I do not claim that juicing or specific foods treat CML.
BCR-ABL Progress
Latest: 0.0030% · 13 October 2026
BCR-ABL1 International Scale · 20 readings
The full 100% International Scale remains in view, with faint MMR (0.1%) and MR4 (0.01%) reference lines. In linear mode, use “Zoom lower range” to inspect individual readings.
Treatment & Diet History
All 20 BCR-ABL visits, newest first. Medication, diet, and remarks are recorded for each visit; scroll within the table for older records. Diet entries are historical observations, not recommendations. Use “View full diet” to read the complete original Notion record.
Scroll horizontally to see medication, diet, and remarks.
| Result / Date | Medication (TKI) | Diet | Remarks |
|---|---|---|---|
| 0.0030%Latest | Dasatinib 70mg a day | Red and green juices; berry smoothie; teas; snack, dinner and fruit. | — |
| 0.0099% | Dasatinib 70mg a day | Red and green juices; berry smoothie; teas; snack, dinner and fruit. | — |
| 0.0034% | Dasatinib 70mg a day | Red and green juices; berry smoothie with mangosteen rind; teas; snack, dinner and fruit. | — |
| 0.003% | Dasatinib 70mg a day | Red and green juices; berry smoothie; teas; snack, dinner and fruit. | — |
| 0.011% | Dasatinib 70mg a day | Red and green juices; berry smoothie; teas; snacks, dinner and fruit. | — |
| 0.011% | Dasatinib 70mg a day | Red, green and yellow juices; berry smoothie; teas; sweet potato, grapes, strawberry and matcha. | Later expanded to red juice, green juice, and berry smoothies. |
| 0.0074% | Dasatinib 70mg a day | Red juice; pineapple, spinach, kale, lettuce, xiao bai cai, celery, bitter gourd, broccoli, apple and lemon; smoothie; teas; microgreens. | — |
| 0.0094% | Dasatinib 70mg | Carrots, purple and red carrots, pomegranate, beetroot and turmeric; pineapple, spinach, kale, lettuce, celery, apple and lemon; smoothie; microgreens. | — |
| 0.014% | Dasatinib 70mg / 140mg | Carrots, beetroot and turmeric; pineapple, spinach, kale, lettuce, celery, apple and lemon; blueberry smoothie; broccoli microgreens. | Reduced dasatinib to 70mg and results still improved. |
| 0.0400% | Dasatinib 70mg / 140mg | 3 kg carrots, 1 kg celery, 500 g beetroot, turmeric, cucumber, broccoli microgreens, moringa powder and oats. | — |
| 0.0472% | dasatinib 140mg | 3 kg carrots, 1½ packs celery, 250 g beetroot. | — |
| 0.06% | dasatinib 140mg | 3 kg carrots, 5 stalks celery, 1 beetroot. | — |
| 0.10% | dasatinib 140mg | 3 kg carrots. | — |
| 0.100% | dasatinib 140mg | Carrots. | — |
| 0.1535% | dasatinib 140mg | Carrots. | — |
| 0.0871% | dasatinib 140mg | 1.5 kg carrots. | Started juicing about 1kg carrots daily. BCR-ABL dropped to about 0.08% after starting carrot juice. |
| 0.2156% | dasatinib 140mg | No diet recorded. | — |
| 0.1575% | dasatinib 140mg | No diet recorded. | — |
| 0.1404% | dasatinib 140mg | No diet recorded. | Switched back to dasatinib 140mg. |
| 0.2175% | nilotonib | No diet recorded. | Switched to nilotinib due to plateau. Nilotinib caused side effects and affected my red blood cells. |
Full original Notion records are available through “View full diet.” Remarks are my own notes and are left blank until I add them.
Journal & Discussion
Journal
Short progress updates, newest first. Drafts remain unpublished until reviewed.
Read the journal →Discussion
Comments and community guidelines live on the dedicated discussion page.
Visit the discussion →